An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders

Table 6

Symptomatology ratings over course of treatment.

	Baseline ()	Week 8 ()	value
Positive and Negative Syndrome Scale
Positive			0.02
Negative			0.99
General			0.88
Calgary Depression Scale			0.22